Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Borcherding

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Science Translational Medicine|June 7, 2023
Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non-small cell lung cancerBrett H Herzog, John M Baer, Nicholas Borcherding, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Epithelial IL-2 is critical for NK cell-mediated cancer immunosurveillance in mammary glandsLei Wang, Chandra K Maharjan, Nicholas Borcherding, et al.
Nature Metabolism|September 2, 2024
Mitochondria transfer-based therapies reduce the morbidity and mortality of Leigh syndromeRitsuko Nakai, Stella Varnum, Rachael L Field, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
The distinct roles of MSH2 and MLH1 in basal-like breast cancer and immune modulationTanzia Islam Tithi, Jiao Mo, Nicholas Borcherding, et al.
Stem Cell Reports|December 31, 2020
AP-2γ Is Required for Maintenance of Multipotent Mammary Stem CellsVivian W Gu, Edward Cho, Dakota T Thompson, et al.
Molecular Cancer Research : MCR|October 18, 2019
A <i>TFAP2C</i> Gene Signature Is Predictive of Outcome in HER2-Positive Breast CancerVincent T Wu, Boris Kiriazov, Kelsey E Koch, et al.
Nature Communications|February 25, 2021
Proteolysis-targeting chimera against BCL-X<sub>L</sub> destroys tumor-infiltrating regulatory T cellsRyan Kolb, Umasankar De, Sajid Khan, et al.
European Journal of Immunology|November 12, 2024
Type I Interferon Drives a Cellular State Inert to TCR-Stimulation and Could Impede Effective T-Cell Differentiation in CancerDillon Corvino, Martin Batstone, Brett G M Hughes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 19, 2026
Highly focused human CD8+ T-cell response in the lower airways during acute influenza infectionAdam Saidu, Jeremy Chase Crawford, Sarah Walden, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2014
Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascadeXuefeng Wu, Weizhou Zhang, Joan Font-Burgada, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Science Translational Medicine|June 7, 2023
Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non-small cell lung cancerBrett H Herzog, John M Baer, Nicholas Borcherding, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Epithelial IL-2 is critical for NK cell-mediated cancer immunosurveillance in mammary glandsLei Wang, Chandra K Maharjan, Nicholas Borcherding, et al.
Nature Metabolism|September 2, 2024
Mitochondria transfer-based therapies reduce the morbidity and mortality of Leigh syndromeRitsuko Nakai, Stella Varnum, Rachael L Field, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
The distinct roles of MSH2 and MLH1 in basal-like breast cancer and immune modulationTanzia Islam Tithi, Jiao Mo, Nicholas Borcherding, et al.
Stem Cell Reports|December 31, 2020
AP-2γ Is Required for Maintenance of Multipotent Mammary Stem CellsVivian W Gu, Edward Cho, Dakota T Thompson, et al.
Molecular Cancer Research : MCR|October 18, 2019
A <i>TFAP2C</i> Gene Signature Is Predictive of Outcome in HER2-Positive Breast CancerVincent T Wu, Boris Kiriazov, Kelsey E Koch, et al.
Nature Communications|February 25, 2021
Proteolysis-targeting chimera against BCL-X<sub>L</sub> destroys tumor-infiltrating regulatory T cellsRyan Kolb, Umasankar De, Sajid Khan, et al.
European Journal of Immunology|November 12, 2024
Type I Interferon Drives a Cellular State Inert to TCR-Stimulation and Could Impede Effective T-Cell Differentiation in CancerDillon Corvino, Martin Batstone, Brett G M Hughes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 19, 2026
Highly focused human CD8+ T-cell response in the lower airways during acute influenza infectionAdam Saidu, Jeremy Chase Crawford, Sarah Walden, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2014
Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascadeXuefeng Wu, Weizhou Zhang, Joan Font-Burgada, et al.
Pageof 9